跳至主要内容
临床试验/CTRI/2012/04/002594
CTRI/2012/04/002594招募中4 期

COMPARISION OF TWO REGIMENS OF LOW DOSE MAGNESIUM SULPHATE FOR TREATMENT OF ECLAMPSIA: LOADING PLUS 24-HOUR MAINTENANCE DOSE VERSUS LOADING DOSE ONLY

未提供1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2011年1月3日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
150
试验地点
1
主要终点
The outcomes of two regimens are compared in terms of

研究概览

简要总结

This study is a randomised, parallel group, open lebel trial compairing the efficacy of  two regimens of low dose magnesium sulphate for the treatment of eclapsia in Indian women. In this trial, two regimens of (low dose) magnesium sulphate in the treatment of eclampsia are compared.

(1) In Control Group: low dose magnesium sulphate (loading plus maintenance dose) is used to control convulsions.

(2) In STUDY Group: Only loading dose of magnesium sulphate will be used (no maintenance dose)  for control of convulsions.

The outcomes of study and control groups are compared in terms of:

(a) Rate of recurrent convulsions in mothers.

(b) Maternal mortality and morbidity

(c) Total amount of magnesium sulphate received by each woman.

(d) Clinical evidence of  magnesium toxicity.

(e) Perinatal mortality and morbidity

This study will explore how efficiently magnesium sulphate can be used for eclampsia without producing maternal toxicity, and avoiding undue prolonged treatment.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • All cases of eclampsia – antepartum, intrapartum, postpartum with following diagnostic criteria: a)Hypertension where BP 140/90 mm Hg or more b)Proteinuria (more than 0.3g/L or more than + 1) c)Convulsion occurring at gestational age > 20 weeks, or within 48 h of delivery.

排除标准

  • Eclampsia with the following conditions will be excluded: a.Renal failure b.Deeply comatosed c.Hypotensive patient d.Clinical or imaging evidence suggestive of intracranial haemorrhage e.Diagnosis is doubtful f.Patients who had other causes of convulsions such as epilepsy, meningitis, trauma, and cerebral malaria etc.

结局指标

主要结局

The outcomes of two regimens are compared in terms of

时间窗: Till discharge

a)Rate of recurrent convulsions

时间窗: Till discharge

b)Maternal mortality

时间窗: Till discharge

次要结局

  • 1. Magnesium Sulphate – a)Total amount of magnesium sulphate received by each patient with or without maintenance dose(b) Total no. of maintenance dose received)

研究者

发起方
未提供

研究点 (1)

Loading locations...

相似试验